China and Hong Kong should relax biotech listing rules, venture capitalist says
South China Morning Post
by Yulu Ao,Julie ZhangMarch 5, 2026
Foreign investors are returning to China’s healthcare sector, but IPO bottlenecks and takeover rules could deter deals, VC Nisa Leung says.
Verticals
worldasia
Originally published on South China Morning Post on 3/5/2026